Delivery Order SPE2DB22D9239-SPE2DB25FDK74
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order with a ceiling value of $18,229.08. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a firm fixed-price arrangement for the delivery of Perjeta 420 mg/14 ml vials. The contract has an ultimate completion date of July 25, 2025. DMS Pharmaceutical Group Inc. has a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) awarded a $4,254.96 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group that allows the DLA to issue delivery orders for a range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The current...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $47,269.80, is for the supply of pharmaceutical products such as Perjeta 420 mg/14 ml vial. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $25,529.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563969889 - Perjeta 420 mg/14 ml vial, 14 ml, with a performance period through April 1, 2024. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24FSW68 with DLA, which has a ceiling value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $17,019.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563691587 PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical products. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, which has a potential value of up to $4,999,999 and enables the agency to...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $4,138.50 under an indefinite delivery contract with the Defense Logistics Agency. The delivery order is for the supply of 14 vials of the pharmaceutical item Perjeta 420 mg/14 ml vial to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. DMS Pharmaceutical Group will provide this product from its facility located in Park Ridge, Illinois, with performance to be completed by...
- This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $34,039.68, is for the delivery of the pharmaceutical product Perjeta (420 mg/14 ml vial, 14 ml) with a completion date of April 19, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, for a broad range of...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,343.62 delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the supply of PERJETA 420 MG/14 ML VIAL 14ML. The contract is a firm fixed-price delivery order with a completion date of July 31, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-four thousand eight hundred thirty-one dollars by the Defense Logistics Agency under an existing indefinite delivery contract. The delivery order is for the supply of fourteen milliliter vials of Perjeta 420 mg to Defense Logistics Agency Troop Support Medical facilities. As a woman-owned small business, DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract through December 2025...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-three thousand one hundred eight dollars by the Defense Logistics Agency. This order is placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceuticals and medical supplies to support military treatment facilities globally. Under this particular order, DMS Pharmaceutical Group will provide fourteen milliliter vials of Perjeta, a breast cancer...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDK74Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $27,343.62 by the Defense Logistics Agency (DLA) on July 25, 2025. The contract calls for the delivery of Perjeta 420 mg/14 ml vials, a targeted cancer therapy used in oncology treatments. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 15, 2025, with performance occurring at the contractor's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which establishes the company as a critical supplier in the federal pharmaceutical supply chain. The SPE2DB program vehicle enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's established federal contract portfolio demonstrates consistent success in supplying specialized pharmaceutical products, including oncology treatments and specialty medications, directly to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.3k | 7/25/25 |